A SMART Design for Attendance-based Prize CM

NCT ID: NCT00840151

Last Updated: 2019-04-09

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 360 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2009-01-31
• Study Completion Date: 2014-08-31

Brief Summary

The purpose of this study is to compare different forms of treatment for substance abuse. This study will involve a type of treatment called contingency management, in which patients receive incentives (prizes) for attending outpatient treatment. This study will compare contingency management to standard treatment that does not involve incentives. This study will also compare contingency management treatment that lasts 6 weeks to contingency management that lasts 12 weeks. Finally, this study will compare contingency management treatment delivered at the beginning of outpatient treatment to contingency management treatment delivered later during outpatient treatment. The investigators hypothesize that (1) a 12-week attendance-based contingency management intervention will improve retention and enhance drug abstinence versus standard treatment, (2) initial short-term exposure to attendance-based contingency management (in weeks 1-6 only) will improve substance abuse treatment outcomes compared to standard treatment alone, and (3) contingency management in weeks 7-12 will be particularly useful for those with sporadic attendance or continued drug use during initial stages of treatment.

Conditions

Substance Abuse

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: FACTORIAL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Treatment Group A

Individuals randomized to Treatment Group A will receive standard treatment for study weeks 1-6.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Treatment Group B

Individuals randomized to Treatment Group B will receive contingency management plus standard treatment for study weeks 1-6.

Group Type: EXPERIMENTAL

contingency management

Intervention Type: BEHAVIORAL

Participants randomized to a contingency management treatment condition can earn the chance to win prizes for attending substance abuse treatment.

Aftercare Group A

All participants will be re-randomized after study week 6. Those participants assigned to Aftercare Group A will receive standard treatment for study weeks 7-12.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Aftercare Group B

All participants will be re-randomized after study week 6. Those participants assigned to Aftercare Group B will receive contingency management treatment plus standard treatment for weeks 7-12.

Group Type: EXPERIMENTAL

contingency management

Intervention Type: BEHAVIORAL

Participants randomized to a contingency management treatment condition can earn the chance to win prizes for attending substance abuse treatment.

Interventions

contingency management

Participants randomized to a contingency management treatment condition can earn the chance to win prizes for attending substance abuse treatment.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• age > 18 years
• current DSM-IV diagnosis of cocaine abuse or dependence or recent cocaine use (self-reported use in past 30 days or positive urine toxicology screen)
• willing to sign informed consent and able to pass an informed consent quiz

Exclusion Criteria

• serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
• in recovery from pathological gambling (meet DSM-IV criteria for lifetime pathological gambling and are actively trying to refrain from gambling)
• do not speak English (all treatment is provided in English at these clinics)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role: collaborator

UConn Health

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Nancy M Petry, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

UConn Health

Locations

University of Connecticut Health Center

Farmington, Connecticut, United States

Countries

United States

Other Identifiers

P50DA009241-16

Identifier Type: NIH

Identifier Source: secondary_id

View Link

09-053-2

Identifier Type: -

Identifier Source: org_study_id